News

The development of a medical healing gel by University of Otago researchers has led to significant financial rewards for the University.
Produced in a joint research project with the University of Adelaide and Wellington-based company Robinson Squidgel, the "healing gel" aids in the post-operative recovery of sinus surgery patients. Leading medical technology company Medtronic bought the patent to the gel in a deal which has been cited as one of the most important commercial deals ever entered into by the University.
 
Speaking to the Otago Daily Times, Deputy Vice-Chancellor Professor Hayne noted the significance of the deal, which "demonstrates the high calibre of the science conducted at Otago". Although the exact financial details remain confidential, Hayne added that a large proportion of the proceeds from the deal will be dedicated to the advancement of future commercial research projects.